Global Brachytherapy Therapy Market 2018-2024: Key Players are Elekta, Varian Medical Systems, C.R. Bard, Eckert & Ziegler BEBIG and Theragenics

5/8/2018, 12:47 PM (Source: GlobeNewswire)

Dublin, May 08, 2018 (GLOBE NEWSWIRE) -- The "Global Brachytherapy Therapy Market 2018-2024" report has been added to's offering.

The Global Brachytherapy Device Market is estimated to witness a CAGR of 6.06% during the forecast period 2018-2024. The market is analyzed based on three segments, namely product type, end-users, and regions.

Asia Pacific and ROW are set to be the emerging regions. The emerging markets have a high potential to grow owing to an increase in the patient population and their focus toward healthcare infrastructure. The brachytherapy devices market has the lowest penetration in the emerging market and most of the vendors are targeting to penetrate countries such as India, China, Thailand, and Vietnam.

APAC is the most focused and has substantial growth due to vast opportunities for vendors to establish their presence. Factors such as growing public awareness, increase in aging population, growing assisted living facilities, presence of large potential customer base, and increased initiatives by government support will boost the market growth. The region is witnessing a rapid growth in the healthcare industry as well.

The emerging countries such as India and China are majorly focusing to improve their healthcare infrastructure and the governments have taken initiatives to develop the healthcare facilities in both urban and rural areas. The increased demand for better services among patients and the increased life expectancy in this region are factors that will boost the overall healthcare facility in the region. Also, countries in this region have a strong focus towards the development of healthcare that will include coverage for patients aged 65 and above.

Brachytherapy devices market is expected to increase rapidly. HDR segment has the maximum share in the global brachytherapy devices market. Developments in imaging technology coupled with advancements in computer technology, have revolutionized the processes for tumor targeting and radiation therapy planning. Technologies used in internal beam radiation therapy include high dose rate (HDR) brachytherapy, low dose rate (LDR) brachytherapy, intermediate dose rate, and pulsed dose rate; and products include seeds, applicators, after loaders, and accessories.

Based on applications, the market is segmented into prostate cancer, cervical cancer, gallbladder, uterus, breast cancer, lung cancer, head & neck cancer, brain cancer, and others. Based on end-users, the market is segmented into hospitals, radiation therapy centers, ambulatory service centers, and others.

Elekta AB, Varian Medical Systems, C.R. Bard (now Becton, Dickinson and Company), Eckert & Ziegler BEBIG SA, and Theragenics are the predominant players in the current brachytherapy devices market.

The global brachytherapy devices market is highly fragmented and has immense growth opportunities for vendors, especially in the developing regions. The market enjoys the participation of many global, regional, and local players who are competing fiercely to gain a strong foothold as top vendor. Big players, such Elekta AB, Varian Medical Systems, and C.R. Bard (now BD) often acquire small yet promising companies to increase their market share.

Most giant companies are using acquisition strategies to expand their business operations by leveraging their products portfoli--across the globe. The competitive environment in the market will intensify further with an increase in product/service extensions, product innovations, and M&A. Strategic alliances are being formed to manufacture and market brachytherapy devices more vigorously and efficiently

Key Stakeholders:

Key Topics Covered:

1 Industry Outlook
1.1 Industry Overview
1.2 Patient Demographics
1.3 Healthcare Spending In The US
1.4 Definition: Brachytherapy
1.5 Why Brachytherapy?
1.6 Industry Trends
1.7 Emerging Global Markets

2 Report Outline
2.1 Report Scope
2.2 Report Summary
2.3 Research Methodology
2.4 Report Assumptions

3 Market Snapshot
3.1 Total Addressable Market (Tam)
3.2 Funding Scenario
3.3 Segmented Addressable Market (Sam)
3.4 Porter 5 (Five) Forces
3.5 Market Dynamics
3.5.1 Drivers Rise In The Incidence Of Cancer Globally Increasing Popularity Of Mi Surgeries Increase In The Number Of Outpatient Procedures Rise In Elderly Population
3.5.2 Restraints Complications And Risks Associated With Brachytherapy Procedures High Costs Of Instrument And Therapy Lack Of Trained Technicians In Developing Countries Intense Competition Among Vendors
3.5.3 Opportunities Advancement In Technology Increasing Adoption Of Non-Invasive Procedures In Emerging Countries Increasing Healthcare Spending Shift Toward Minimal And Non-Invasive Procedures
3.5.4 DRO - Impact Analysis
3.5.5 Key Stakeholders

4 Brachytherapy Market Segmentation By Methods: Market Size & Analysis
4.1 Overview
4.2 High-Dose Rate Brachytherapy Market
4.3 Low-Dose Rate Brachytherapy Market
4.4 Intermediate Dose Rate Brachytherapy Market
4.5 Pulsed Dose Rate Brachytherapy Market

5 Brachytherapy Market Segmentation By Consumables
5.1 Overview
5.2 Seeds
5.3 Applicators, Afterloaders, And Other Accessories

6 Brachytherapy Market Segmentation By Applications
6.1 Overview
6.2 Prostate Cancer
6.3 Cervical Cancer
6.4 Breast Cancer
6.5 Lung Cancer
6.6 Head & Neck Cancer
6.7 Brain Cancer
6.8 Others

7 End-Users: Market Size And Analysis
7.1 Overview
7.2 Hospitals
7.3 Radiation Therapy Centers
7.4 Ambulatory Surgery Centers
7.5 Others

8 Regions: Market Size & Analysis

9 Competitive Landscape

10 Vendor Profiles
10.1 Elekta AB
10.2 Varian Medical Systems Inc.
10.3 C. R. Bard Inc.
10.4 Eckert & Ziegler Bebig
10.5 Theragenics Corp

11 Companies To Watch For
11.1 Carl Zeiss Meditec AG
11.2 Mevion Medical Systems Inc.
11.3 Nordion Inc.
11.4 Isoray Inc.
11.5 Hitachi Medical Corp.

For more information about this report visit

         Laura Wood, Senior Manager
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900
         Related Topics: Nuclear Medicine and Radiopharmacology

Primary Logo

Copyright GlobeNewswire, Inc. 2016. All rights reserved.
You can register yourself on the website to receive press releases directly via e-mail to your own e-mail account.